Investor MBA Business Plan for Infant Wearable Device Bridging B2C & Medical
Preferred learners
- Anywhere
- Academic experience
Categories
Skills
Project scope
- What is the main goal for this project?
-
Investor MBA Business Plan for Infant Wearable Device Bridging B2C & Medical
A) Consumer (B2C) – Puffin™
B) Medical (B2M) CHIME™ - Clinical Health Infant Monitoring Ecosystem
Project Outline
A business plan for pre-series ‘A’ investment, covering a 5year projection - including: strategy, brand development, market/ competitor analysis and planning dynamic spreadsheet (SS) business P&L, Cash flows, Balance sheet and markets pre-investment.
In parallel we will continue to develop the medical compliance which can take several years hence the 5yrs plan rather than the typical 3yrs projection.
A convincing business plan needs to validate the value proposition for a B2C market with supporting health economics around B2M infant care in hospital, GP surgeries, care in community.
With the advent and rapid changing landscape re COVID, there is a sea change in medical/consumer behaviours that are now ready to adopt this bridge between consumer/medical with a trusted device for remote vital signs monitoring. We need a fresh look at the socio-economics and business planning, resulting in a convincing business plan and documentation to inspire and secure investment.
Currently we are planning to undertake a crowdfunding campaign in Sept’21 to capture early B2C adopters, revenues, data on healthy infants CE mark approval and penetrate UK and then overseas markets. In parallel, we will continue to progress the development of the medical product which can take 3-4 years to get medical approval/compliance.
We have early traction with two medical focuses where we are placing this device:
1) Cardio-Respiratory/Bronchiolitis impacting 1:3 infants,
2) An out-research initiative (working title ‘PATCH’) initiated by a UK, NHS (National Health Service) hospital using our device to remotely monitor infants at home.
An underlining market statistic driver: there are, according to Public Health England, 700,000 births in the UK compared to 22+million visits to hospital A&E by parents with an infants under 5yrs, 85% of these infants are under 1yrs old. Brit. Medical Assoc. believes 30% of these visits (approx.6m) can be addressed at home reducing pressure on medical resources and cost to families and ensuing disruption to their lives, finance (absenteeism) and routines.
- What is the main goal for this project?
-
Investor MBA Business Plan for Infant Wearable Device Bridging B2C & Medical
A) Consumer (B2C) – Puffin™
B) Medical (B2M) CHIME™ - Clinical Health Infant Monitoring Ecosystem
Project Outline
A business plan for pre-series ‘A’ investment, covering a 5year projection - including: strategy, brand development, market/ competitor analysis and planning dynamic spreadsheet (SS) business P&L, Cash flows, Balance sheet and markets pre-investment.
In parallel we will continue to develop the medical compliance which can take several years hence the 5yrs plan rather than the typical 3yrs projection.
A convincing business plan needs to validate the value proposition for a B2C market with supporting health economics around B2M infant care in hospital, GP surgeries, care in community.
With the advent and rapid changing landscape re COVID, there is a sea change in medical/consumer behaviours that are now ready to adopt this bridge between consumer/medical with a trusted device for remote vital signs monitoring. We need a fresh look at the socio-economics and business planning, resulting in a convincing business plan and documentation to inspire and secure investment.
Currently we are planning to undertake a crowdfunding campaign in Sept’21 to capture early B2C adopters, revenues, data on healthy infants CE mark approval and penetrate UK and then overseas markets. In parallel, we will continue to progress the development of the medical product which can take 3-4 years to get medical approval/compliance.
We have early traction with two medical focuses where we are placing this device:
1) Cardio-Respiratory/Bronchiolitis impacting 1:3 infants,
2) An out-research initiative (working title ‘PATCH’) initiated by a UK, NHS (National Health Service) hospital using our device to remotely monitor infants at home.
An underlining market statistic driver: there are, according to Public Health England, 700,000 births in the UK compared to 22+million visits to hospital A&E by parents with an infants under 5yrs, 85% of these infants are under 1yrs old. Brit. Medical Assoc. believes 30% of these visits (approx.6m) can be addressed at home reducing pressure on medical resources and cost to families and ensuing disruption to their lives, finance (absenteeism) and routines.
- What tasks will learners need to complete to achieve the project goal?
-
No deliverables exist for this project.
About the company
- http://futurecareuk.com/
- 0 - 1 employees
- Retail, Technology, Education, Hospital, health, wellness & medical, Consumer goods & services
Future Care(FC) is an SME based in London, UK. Our R&D is focused on a bespoke, wearable, non-invasive, medical precision instrument for infants (0-24months), remotely monitoring vital signs and integrated stethoscope, linked to a predictive & preventative analytics platform, Reports and Alarms sent to end user consumer (B2C) and medical (B2M) APPS.
FC works closely with ARROW is a $30B international electronics company and their partners e.g. Microsoft.